Top compounds associated with response to TRMT2B


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan FIMM pan-cancer AAC 0.054 0.6
mRNA Cytarabine FIMM pan-cancer AAC -0.078 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.017 0.6
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC 0.022 0.6
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA CGP-082996 GDSC1000 pan-cancer AAC 0.025 0.6
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Panobinostat FIMM pan-cancer AAC 0.056 0.6
Download CSV